IDH1 and glioma: Additionally, another four potential antigens including TP53, IDH1, C3 and TCF12, have been identified as significant contributors to glioma growth intensity and have the capacity for direct procession and presentation to CD8 T cells when there is sufficient lymphocyte infiltration to induce an immune response (15).